Interaction of Azoles with Rifampin, Phenytoin, and Carbamazepine: In Vitro and Clinical Observations

Clinical Infectious Diseases

Volumn 14, Issue 1, 1992, Pages 165-174

  Tucker, Richard M ^a,b,c,d,e,f   Denning, David W ^a,b,c,d,e,f   Hanson, Linda H ^a,b,c,d,e,f   Rinaldi, Michael G ^a,b,c,d,e,f   Graybill, John R ^a,b,c,d,e,f   Kay Sharkey, P ^a,b,c,d,e,f   Pappagianis, Demosthenes ^a,b,c,d,e,f   Stevens, David A ^a,b,c,d,e,f  

^a CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Wenatchee Valley Clinic   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; PHENYTOIN; RIFAMPICIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BIOASSAY; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INTERACTION; DRUG POTENTIATION; FEMALE; FUNGICIDAL ACTIVITY; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; PERSISTENT INFECTION; PHARMACOKINETICS; PRIORITY JOURNAL; RELAPSE;

ADULT; AGED; ANTIFUNGAL AGENTS; AZOLES; CARBAMAZEPINE; COCCIDIOIDES; CRYPTOCOCCUS NEOFORMANS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; FLUCONAZOLE; HUMAN; ITRACONAZOLE; KETOCONAZOLE; MALASSEZIA; MALE; MIDDLE AGE; MYCOSES; PHENYTOIN; RIFAMPIN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026531324     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/14.1.165     Document Type: Article

References (40)

1. Dismukes WE Azole antifungal drugs: old and new. Ann Intern Med 1988;109:177-9.
2. Stevens DA. The new generation of antifungal drugs. Eur J Clin Microbiol Infect Dis 1988;7:735-7.
3. Tucker RM, Williams PL, Arathoon EA, Stevens DA. Treatment of mycoses with itraconazole. Ann N Y Acad Sci 1988;544:451-70.
4. Tucker RM, Williams PL, Arathoon EA, Hartstein AI, Hanson L, Stevens DA. Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis. Antimicrob Agents Chemother 1988;32:369-73.
5. Brass C, Galgiani JN, Blaschke TF, Defelice R, O’Reilly RA, Stevens DA. Disposition of ketoconazole, an oral antifungal, in humans, Antimicrob Agents Chemother 1982;21:151-8.
6. Huppert M, Pappagianis D, Sun SH, Gleason-Jordan I, Collins MS, Vukovich K.R. Effect of amphotericin B and rifampin against Coc- cidioides immitis in vitro and in vivo. Antimicrob Agents Chemother 1976;9:406-13.
7. Faergemann J. In vitro and in vivo activities of ketoconazole and itraconazole against Pilyrosporum orbiculare. Antimicrob Agents Chemother 1980;2:1984.
8. Rinaldi MG. Use of potato flakes agar in clinical mycology. J Clin Microbiol 1982; 15:1159-60.
9. Hoeprich PD, Huston AC. Susceptibility of Coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole. J Infect Dis 1975;132:133-41.
10. Hector RF, Zimmer BL, Pappagianis D. Microtiter method for MIC testing with spheruie-endospore phase Coccidioides immitis. J Clin Microbiol 1988;26:2667-8.
11. Elion G, Singer S, Hitchings G. Antagonism of nucleic acid derivatives. J Biol Chem 1954;208:477-88.
12. Stevens DA, Vo PT. Synergistic interaction of trimethoprim and sulfamethoxazole on Paracoccidioides brasiliensis. Antimicrob Agents Chemother 1982;21:852-4.
13. Denning DW, Tucker RM, Hanson LH, Hamilton JR, Stevens DA. Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch Intern Med 1989;149:2301-8.
14. Tucker RM, Denning DW, Arathoon EG, Rinaldi MG, Stevens DA. Itraconazole therapy of non-meningeal coccidioidomycosis: clinical and laboratory observations. J Am Acad Dermatol 1990;23:593- 601.
15. Doble N, Shaw R, Rowland-Hill C, Lush M, Warnock DW, Keal EE. Pharmacokinetic study of the interaction between rifampicin and ketoconazole. J Antimicrob Chemother 1988;21:633-5.
16. Abadie-Kemmerly S, Pankey GA, Dalvisio JR. Failure of ketoconazole treatment of Blastomyces dermatitidis due to interaction of isoniazid and rifampin. Ann Intern Med 1988;109:844-5.
17. Englehard D, Stutman HR, Marks MI. Interaction ofketoconazole with rifampin and isoniazid. N Engl J Med 1984;311:1681-3.
18. Doble N, Hykin P, Shaw R, Keal EE. Pulmonary Mycobacterium tuberculosis in acquired immune deficiency. BMJ 1985;291:849-50.
19. Centers for Disease Control. Diagnosis and management of mycobacterial infection and disease in persons with human immunodeficiency virus infection. Ann Intern Med 1987;106:254-6.
20. Meunier F. Serum fungistatic and fungicidal activity in volunteers receiving antifungal agents. Eur J Clin Microbiol 1986;5:103-9.
21. Faergemann J, Fredriksson T. Experimental infections in rabbits and humans with Pityrosporum orbiculare and Pityrosporum ovale. J Invest Dermatol 1981;77:314-8.
22. Rifkind D, Crowder ED, Hyland RH. In vitro inhibition of Coccidioides immitis strains with amphotericin B plus rifampin. Antimicrob Agents Chemother 1974;6:783-4.
23. Browne TR, Szabo GK, Evans JE, Evans BA, Greenblatt DJ, Mikati MA. Carbamazepine increases phenytoin serum concentration and reduces phenytoin clearance. Neurology 1988;38:1146-50.
24. Denning DW, Tucker RM, Hanson LH, Stevens DA. Treatment of invasive aspergillosis with itraconazole. Am J Med 1989;86:791- 800.
25. Foulds G, Wajszczuk C, Weidler DJ, Garg DJ, Gibson P. Steady state parenteral kinetics of fluconazole in man. Ann N Y Acad Sci 1988;544:427-30.
26. Tucker RM, Galgiani JN, Denning DW, et al. Treatment of coccidioi-dal meningitis with fluconazole. Rev Infcct Dis 1990;12(suppl 3):S380-9.
27. Sugar AM, Saunders C. Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome. Am J Med 1988;85:481-9.
28. Lazar JD, Wilner KD. Drug interactions with fluconazole. Rev Infect Dis 1990;12(suppl 3):S327-33.
29. Dupont B, Drouhet E. Fluconazole in the management of oropharyngeal candidosis in a predominantly HIV antibody-positive group of patients. J Med Vet Mycol 1988;26:67-71.
30. Ferguson RM, Sutherland DER, Simmons RL, Najarían JS. Ketoconazole, cyclosporin metabolism and renal transplantation. Lancet 1982;2:882-3.
31. Dieperink H, Maller J. Ketoconazole and cyclosporin [letter]. Lancet 1982;2:1217.
32. Schroeder TJ, Melvin DB, Clardy CW, et al. Use of cyclosporin and ketoconazole without nephrotoxicity in two heart transplantation recipients. Journal of Heart Transplantation 1987;6:84-9.
33. Kwan JTC, Foxall PJD, Davidson DGC, Bending MR, Eisinger AJ. Interaction of cyclosporin and itraconazole [letter]. Lancet 1987;2:282.
34. Trenk D, Brett W, Jahuchen E, Birnbaum D. Time course of cyclosporin/itraconazole interaction [letter]. Lancet 1987;2:1335-6.
35. Novakova I, Donnelly P, de Pauw B, Boezeman J, Veltman G. Itraconazole and cyclosporin nephrotoxicity [letter]. Lancet 1987;2:920-1.
36. Kramer MR, Marshall SE, Denning DW, et al. Drug interaction between cyclosporin and itraconazole in heart, heart-lung and lung transplant recipients with fungal disease. Ann Intern Med 1990; 113:327-9.
37. Stiller RL, Bennett JE, Scholer HJ, Wall M, Polak A, Stevens DA. Correlation of in vitro susceptibility test results with in vivo response: flucytosine therapy in a systemic candidiasis model. J Infect Dis 1983;147:1070-7.
38. Powderly W, Kobayashi G, Herzig G, Medoff G. Amphotericin B-re- sistant yeast infection in severely immunocompromised patients. Am J Med 1988;84:826-32.
39. Dworzack DL, Clark RB, Borkowski WJ. PseudaUescheria boydii brain abscess: association with near-drowning and efficacy of high-dose, prolonged miconazole therapy in patients with multiple abscesses. Medicine 1989;68:218-24.
40. Denning DW, Tucker RM, Hostetler JS, Gill S, Stevens DA. Oral itraconazole therapy of cryptococcal meningitis and cryptococcosis in patients with AIDS. In: Vanden Bossche H, MacKenzie DWR, Cau- wenbergh G, Drouhet E, Dupont B, Van Cutsem J, eds. Mycoses in AIDS patients. New York: Plenum Press, 1990:305-24.